Aug 15, 2023, 01:00 by User Not Found

Clinical Research News | Clinical research stakeholders, most especially study sponsors, are now firmly onboard with the idea of using artificial intelligence (AI) to improve the conduct of clinical trials.

Aug 11, 2023, 10:08 by

X-Chem, the leading provider of innovative solutions in early-stage drug discovery, announced the addition of Karen Lackey as chief scientific officer (CSO) and David Hagerman as chief financial officer (CFO) to its global executive management team.

Aug 11, 2023, 01:00 by User Not Found

Clinical Research News | A point-of-care (POC) diagnostic test for long COVID is under development that would be a godsend to the millions of Americans still suffering the health consequences of SARS-CoV-2 months after being infected.

Aug 10, 2023, 09:24 by

Phastar Appoints Graham Clark as New Chief Executive Officer Phastar Sets Course for Further Growth with New CEO Appointment

Aug 10, 2023, 09:24 by

Mtech Access has announced that its annual NHS Transformation Symposium, this September, will feature guest speakers Penny Dash and Paul Miller, who hold strategic leadership roles in an Integrated Care Systemand Board, respectively.

Aug 10, 2023, 09:24 by

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023

Aug 9, 2023, 09:03 by

About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

Aug 8, 2023, 13:14 by

iotaSciences has announced today the appointment of Dr. Michael Lutz as CEO and Director for Iota Sciences Ltd.

Aug 8, 2023, 09:28 by

Kiora Pharmaceuticals of Encinitas announced a sharpened focus on its KIO-310 vision-restoring treatments for retinal diseases. This is based largely on preliminary results observed in a recent ABACUS Phase 1b clinical trial that indicates the possibility KIO-310 could treat Retinitis Pigmentosa, Choroideremia, and Stargardt’s Disease.

Aug 8, 2023, 01:00 by User Not Found

Clinical Research News | The COVID-19 pandemic amplified a lot of existing weaknesses in the healthcare system, and clinical research was no exception: less than 5% of the nation partakes in clinical trials and 75% of those participants are white. This disparity indicates that drugs undergoing clinical trials don’t necessarily have the same effect on the rest of the American population, particularly those from ethnic and racial minority groups.

Aug 7, 2023, 09:02 by

United BioSource, LLC (UBC), the leading provider of evidence-based research for the biopharma industry, has migrated its safety functions from on-premises to Oracle Argus Cloud Service, a trusted safety case management solution. UBC specializes in generating real-world evidence of product effectiveness, safety, and value that enable emerging and leading pharmaceutical companies to make medicine and specialty therapies safer and more accessible.

Aug 4, 2023, 01:00 by User Not Found

Clinical Research News | Clinical research should be a viable option for everyone who wishes to participate. Sponsors know that diverse trials lead to stronger data and better drugs, yet there are many obstacles to recruiting and retaining diverse participants – from distrust, to lack of access, to financial and logistical barriers.

Aug 3, 2023, 09:46 by

Dr. Vince Clinical Research (DVCR), a full-service CRO specializing in Phase I-II clinical trials, announced today the first subject was screened for Cessation Therapeutics’ CSX-1004 in a First-In-Human single ascending dose study in normal healthy volunteers. CSX-1004 is a human monoclonal antibody infusion that is being developed for the prevention of fentanyl overdose.

Aug 3, 2023, 09:39 by

Kiora Pharmaceuticals and the Choroideremia Research Foundation (located in Springfield MA) have partnered to advance a potential new treatment for patients with choroideremia (CHM), a rare, inherited retinal disease that causes blindness. This collaboration will accelerate Kiora's development of a small molecule designed to restore vision in patients with later-stage retinal degeneration. Key Takeaways: Patients with CRM are often initially misdiagnosed with retinitis pigmentosa (RP), as these two conditions have similar symptoms. People with CHM can expect their peripheral vision to get worse over time, leaving only central vision. Eventually, the condition may progress to blindness. There isn't a cure but the partnership between Kiora and CRF could eventually help restore vision. CRF will assist Kiora with access to clinical and scientific thought leaders to assist in further development of KIO-301, a small molecule designed to restore vision in patients with later-stage retinal degeneration. CRF will also provide aid in enrollment of patients for any future trials of KIO-301.

Aug 3, 2023, 01:00 by User Not Found

Clinical Research News | A team of researchers from North America and Europe have identified a panel of 83 markers in the blood of children genetically predisposed to develop type 1 diabetes that looks promising as a predictor of which individuals will progress to islet autoimmunity six months prior to its onset.

Aug 2, 2023, 09:21 by

Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.

Aug 2, 2023, 09:06 by

Expert Speaker Lineup Revealed for Award Winning RBQM Event Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.

Aug 2, 2023, 09:06 by

The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.

Aug 1, 2023, 01:00 by User Not Found

Clinical Research News | Randomized controlled trials are a fantastic first step in assessing the clinical effects of medical interventions, but they are not sufficient to transform the “busy throughput environment” of real-world healthcare involving appointment scheduling and referrals, differing practice patterns, and patients with comorbidities and social determinants of health like housing instability and low literacy skills.

Jul 27, 2023, 01:00 by User Not Found

Clinical Research News | Researchers from around the world are invited to publicly design a shared brain experiment that will run on the Allen Brain Observatory, Angry@Arthritis has announced the first global osteoarthritis clinical trial locator, Indiana Sickle Cell Data Collection program published a paper on persons living with the disease in the state, and Boston Scientific received FDA approval to new software. Plus, new product updates and partnerships from Arrayjet, Critical Path Institute, Clinisys, and more.